Sernova Biotherapeutics (OTCMKTS:SEOVF) Issues Quarterly Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) announced its quarterly earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01), Zacks reports.

Sernova Biotherapeutics Stock Performance

Shares of SEOVF opened at $0.10 on Friday. Sernova Biotherapeutics has a one year low of $0.07 and a one year high of $0.14. The stock’s fifty day moving average is $0.08 and its 200-day moving average is $0.10. The firm has a market capitalization of $38.29 million, a price-to-earnings ratio of -2.54 and a beta of 0.86.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.